Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3275930
Max Phase: Preclinical
Molecular Formula: C74H93N16O13S+
Molecular Weight: 1446.72
Molecule Type: Protein
Associated Items:
ID: ALA3275930
Max Phase: Preclinical
Molecular Formula: C74H93N16O13S+
Molecular Weight: 1446.72
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=S)Nc1ccc(-c2c3ccc(=[N+](C)C)cc-3oc3cc(N(C)C)ccc23)cc1)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
Standard InChI: InChI=1S/C74H92N16O13S/c1-9-42(4)64(70(99)83-56(35-47-39-77-40-79-47)71(100)90-32-14-18-58(90)68(97)84-57(72(101)102)34-43-15-11-10-12-16-43)87-67(96)54(33-44-19-27-50(91)28-20-44)82-69(98)63(41(2)3)86-65(94)53(17-13-31-78-73(75)76)81-66(95)55(38-61(92)93)85-74(104)80-46-23-21-45(22-24-46)62-51-29-25-48(88(5)6)36-59(51)103-60-37-49(89(7)8)26-30-52(60)62/h10-12,15-16,19-30,36-37,39-42,53-58,63-64H,9,13-14,17-18,31-35,38H2,1-8H3,(H15,75,76,77,78,79,81,82,83,84,85,86,87,91,92,93,94,95,96,97,98,99,101,102,104)/p+1/t42-,53-,54-,55-,56-,57-,58-,63-,64-/m0/s1
Standard InChI Key: PFVJLLRYRBAVBY-FMPQGJHCSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1446.72 | Molecular Weight (Monoisotopic): 1445.6823 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Galardy RE, Stafford SS, Schaefer ML, Ho H, La Vorgna KA, Jamieson JD.. (1978) Biologically active derivatives of angiotensin for labeling cellular receptors., 21 (12): [PMID:214560] [10.1021/jm00210a020] |
Source(1):